Aptose Biosciences (TSE:APS) Stock Crosses Below 200-Day Moving Average – Here’s What Happened

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$1.18 and traded as low as C$0.51. Aptose Biosciences shares last traded at C$0.51, with a volume of 1,510 shares trading hands.

Aptose Biosciences Stock Down 2.0 %

The firm’s fifty day moving average is C$0.59 and its two-hundred day moving average is C$1.17. The firm has a market cap of C$9.06 million, a price-to-earnings ratio of -0.09 and a beta of 1.36. The company has a debt-to-equity ratio of 670.80, a current ratio of 0.80 and a quick ratio of 5.41.

Aptose Biosciences (TSE:APS) (NASDAQ:APTO) last posted its quarterly earnings data on Thursday, August 8th. The biotechnology company reported C($0.59) earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.80) by C$0.21. On average, sell-side analysts expect that Aptose Biosciences Inc. will post -0.59 EPS for the current fiscal year.

About Aptose Biosciences

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.